Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

94.54EUR
9 Dec 2016
Change (% chg)

€1.37 (+1.47%)
Prev Close
€93.17
Open
€93.95
Day's High
€94.73
Day's Low
€93.06
Volume
3,269,236
Avg. Vol
2,280,577
52-wk High
€119.05
52-wk Low
€83.45

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic... (more)

Overall

Beta: 0.93
Market Cap(Mil.): €78,179.65
Shares Outstanding(Mil.): 826.95
Dividend: 2.50
Yield (%): 2.64

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 17.33 29.73 30.40
EPS (TTM): 5.45 -- --
ROI: 8.32 15.87 15.24
ROE: 19.66 16.99 16.58

French add to U.S. concerns about Bayer contraceptive implant

PARIS Women in France who have used Bayer's contraceptive implant Essure have launched a legal complaint about side-effects similar to a challenge already underway in the United States.

Dec 09 2016

Bracco, Guerbet looking for partners for Bayer radiology bids: sources

FRANKFURT Italian healthcare group Bracco is working on a potential bid for the radiology supplies unit that Germany's Bayer AG is considering selling, people close to the matter said.

Dec 07 2016

BRIEF-Monsanto provides update on Bayer merger

* Monsanto co - in connection with merger with Bayer, a purported class action lawsuit, captioned ken gawrych, was filed on nov. 16, 2016

Nov 22 2016

European shares weighed down by weaker banks, Bayer drop

* Hugo Boss slumps as revival plan seen taking time (ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)Adds detail, closing prices)

Nov 16 2016

BRIEF-Bayer places 4 bln euros of mandatory convertible notes

* Says successfully places EUR 4 billion of mandatory convertible notes

Nov 15 2016

Bayer to raise four billion euros via convertible notes for Monsanto deal

LONDON/BERLIN German chemicals and healthcare group Bayer AG is selling 4 billion euros ($4.3 billion) worth of mandatory convertible notes to help fund its proposed acquisition of U.S. seeds company Monsanto Co .

Nov 15 2016

UPDATE 1-Bayer to raise 4 bln euros via convertible notes for Monsanto deal

* Proceeds will be used for $66 bln Monsanto buy (Adds comment by banker, background)

Nov 15 2016

BRIEF-Germany's Bayer mandatory convertible bond issue covered - source

* 4 billion euro mandatory convertible bond issue covered - source (Reporting by Dasha Afanasieva)

Nov 15 2016

Bayer to issue convertible notes for Monsanto buy

BERLIN, Nov 15 German chemicals and healthcare group Bayer AG will issue 4 billion euros ($4.3 billion) in mandatory convertible notes as part of measures to fund its acquisition of U.S. seeds company Monsanto Co.

Nov 15 2016

BRIEF-Bayer to issue convertible notes for Monsanto buy

* Bayer to issue mandatory convertible notes Source text for Eikon: Further company coverage: (Reporting by Frankfurt Newsroom)

Nov 15 2016

Earnings vs. Estimates